These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


240 related items for PubMed ID: 7838133

  • 21. Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line.
    Baas F, Jongsma AP, Broxterman HJ, Arceci RJ, Housman D, Scheffer GL, Riethorst A, van Groenigen M, Nieuwint AW, Joenje H.
    Cancer Res; 1990 Sep 01; 50(17):5392-8. PubMed ID: 1974823
    [Abstract] [Full Text] [Related]

  • 22. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
    Pan L, Tong Y, Jin Y, Zhou S, Zhang Y, Yang X, Mao N.
    Chin Med J (Engl); 2001 Sep 01; 114(9):929-32. PubMed ID: 11780384
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC, Liang YC, Klutz A, Hsu CI, Lin CF, Mold DE, Chou TC, Lee YC, Huang RC.
    Cancer Chemother Pharmacol; 2006 Nov 01; 58(5):640-53. PubMed ID: 16544145
    [Abstract] [Full Text] [Related]

  • 25. Antimultidrug-resistant effect and mechanism of a novel CA-4 analogue MZ3 on leukemia cells.
    Xu D, Fang L, Zhu Q, Hu Y, He Q, Yang B.
    Pharmazie; 2008 Jul 01; 63(7):528-33. PubMed ID: 18717489
    [Abstract] [Full Text] [Related]

  • 26. Cytometric study of intracellular P-gp expression and reversal of drug resistance.
    Labroille G, Belloc F, Bilhou-Nabera C, Bonnefille S, Bascans E, Boisseau MR, Bernard P, Lacombe F.
    Cytometry; 1998 Jun 01; 32(2):86-94. PubMed ID: 9627221
    [Abstract] [Full Text] [Related]

  • 27. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
    Ramachandran C, Wellham LL.
    Anticancer Res; 2003 Jun 01; 23(3B):2681-90. PubMed ID: 12894558
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax.
    Li X, Hong L, Zhao Y, Jin H, Fan R, Du R, Xia L, Luo G, Fan D.
    Biochem Cell Biol; 2007 Dec 01; 85(6):741-50. PubMed ID: 18059532
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Expression of the human multidrug resistance gene mdr1 in leukemic cells and its application in studying P-glycoprotein antagonists.
    Fu J, Chen Z, Cen J, Ruan C.
    Chin Med J (Engl); 2000 Mar 01; 113(3):228-31. PubMed ID: 11775252
    [Abstract] [Full Text] [Related]

  • 35. Selection of antisense oligonucleotides for reversal of multidrug resistance in breast carcinoma cells.
    Gao P, Zhou GY, Lei DP, Zhang XF, Li L, Xu JW, Lin XY.
    Cytotherapy; 2007 Mar 01; 9(8):795-801. PubMed ID: 17917879
    [Abstract] [Full Text] [Related]

  • 36. Transcriptional regulation of rat microsomal epoxide hydrolase gene by imidazole antimycotic agents.
    Kim SG.
    Mol Pharmacol; 1992 Aug 01; 42(2):273-9. PubMed ID: 1513325
    [Abstract] [Full Text] [Related]

  • 37. Post-transcriptional regulation of P-glycoprotein expression in cancer cell lines.
    Gómez-Martínez A, García-Morales P, Carrato A, Castro-Galache MD, Soto JL, Carrasco-García E, García-Bautista M, Guaraz P, Ferragut JA, Saceda M.
    Mol Cancer Res; 2007 Jun 01; 5(6):641-53. PubMed ID: 17579122
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of MDR1 gene expression by antimessenger oligonucleotides lowers multiple drug resistance.
    Quattrone A, Papucci L, Morganti M, Coronnello M, Mini E, Mazzei T, Colonna FP, Garbesi A, Capaccioli S.
    Oncol Res; 1994 Jun 01; 6(7):311-20. PubMed ID: 7865906
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Proton nuclear magnetic resonance spectroscopy reveals cellular lipids involved in resistance to adriamycin and taxol by the K562 leukemia cell line.
    Le Moyec L, Tatoud R, Degeorges A, Calabresse C, Bauza G, Eugène M, Calvo F.
    Cancer Res; 1996 Aug 01; 56(15):3461-7. PubMed ID: 8758912
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.